Radiation Oncology/Therapy: Page 37

Radsource installs ProtonPACS in Q1

By AuntMinnie.com staff writers

Radsource completed 11 installations of its ProtonPACS software at new and existing customers in the first quarter of 2022, the company said.

April 14, 2022

ITM, MTTI ink lutetium-177 supply deal

By AuntMinnie.com staff writers

ITM Isotope Technologies Munich's subsidiary ITM Medical Isotopes and biopharmaceutical company Molecular Targeting Technologies (MTTI) have signed a supply deal for no-carrier-added lutetium-177.

April 12, 2022

NYSE accepts Navidea bid to comply with stock listing rules

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals said the New York Stock Exchange (NYSE) has accepted its plan to regain compliance with the stock exchange's listing requirements. Navidea now has until July 28, 2023, to regain compliance.

April 12, 2022

Radionetics Oncology taps de Silva as CEO

By AuntMinnie.com staff writers

Pharmaceutical firm Radionetics Oncology has named Dr. Nishan de Silva as CEO and a director of the company's board. De Silva most recently was with AFYX Therapeutics.

April 11, 2022

FDA clears clinical trial for Blue Earth radiopharmaceutical

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has given the go-ahead to Blue Earth Therapeutics to conduct a clinical study of its radiopharmaceutical labeled with lutetium-177 for treatment of metastatic, castrate-resistant prostate cancer.

April 11, 2022

Sun Nuclear releases SaaS option for SunCheck

By AuntMinnie.com staff writers

Radiation oncology quality-assurance technology developer Sun Nuclear has released a cloud-hosted software-as-a-service (SaaS) option for its SunCheck radiation therapy quality assurance management platform.

April 10, 2022

RaySearch inks deal with Mevion China

By AuntMinnie.com staff writers

Radiation therapy software developer RaySearch Laboratories has signed an agreement to deliver its RayStation treatment planning software to Mevion China.

April 7, 2022

Zr-89 tracer helps PET detect subtle prostate cancer lesions

By Will Morton

An experimental zirconium-89-based (Zr-89) PET radiotracer can detect tumors missed by existing tracers in patients whose cancer has returned after surgery or radiotherapy, according to a study published in the April 1 issue of the Journal of Nuclear Medicine.

April 7, 2022

CMS again delays start of RO Model for radiation therapy payments

By Brian Casey

A major restructuring of the way the U.S. Centers for Medicare and Medicaid Services (CMS) pay for radiation therapy treatments, the Radiation Oncology Alternative Payment Model (RO Model), has been delayed again -- this time into the indefinite future.

April 5, 2022

RaySearch brings RayStation to facility in Hong Kong

By AuntMinnie.com staff writers

Radiation therapy software developer RaySearch Laboratories has signed a deal to deliver its RayStation treatment planning software to the Hong Kong Sanitorium & Hospital.

April 5, 2022

IBA to partner with Dutch hospital on breast cancer research

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) and the University Medical Center Groningen in the Netherlands will collaborate on research into flash radiation therapy for breast cancer.

April 5, 2022

MIM Software inks deal with Videra Surgical

By AuntMinnie.com staff writers

MIM Software and oncology surgery company Videra Surgical are teaming up on a new partnership involving breast cancer radiation therapy.

April 4, 2022

Previous Page

Page 37 of 468

Next Page